aggressive prostate cancer models Search Results


aggressive prostate cancer  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare aggressive prostate cancer
Baseline and clinical characteristics of the <t> aggressive prostate cancer </t> cases *
Aggressive Prostate Cancer, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aggressive prostate cancer/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
aggressive prostate cancer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
biological aggressiveness of prostate cancer in the finnish screening trial  (Biolog Inc)
90
Biolog Inc biological aggressiveness of prostate cancer in the finnish screening trial
Baseline and clinical characteristics of the <t> aggressive prostate cancer </t> cases *
Biological Aggressiveness Of Prostate Cancer In The Finnish Screening Trial, supplied by Biolog Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biological aggressiveness of prostate cancer in the finnish screening trial/product/Biolog Inc
Average 90 stars, based on 1 article reviews
biological aggressiveness of prostate cancer in the finnish screening trial - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Baseline and clinical characteristics of the aggressive prostate cancer cases *

Journal: The Prostate

Article Title: Association of CASP8 D302H Polymorphism with Reduced Risk of Aggressive Prostate Carcinoma

doi: 10.1002/pros.21098

Figure Lengend Snippet: Baseline and clinical characteristics of the aggressive prostate cancer cases *

Article Snippet: Our interest was to determine if this variant was related to aggressive prostate cancer, in materials from two case control studies of aggressive prostate cancer at Washington University and Johns Hopkins University and in aggressive cases of this disease identified in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

Techniques: Biomarker Discovery

Risk of aggressive prostate cancer associated with the CASP8 D302H polymorphism

Journal: The Prostate

Article Title: Association of CASP8 D302H Polymorphism with Reduced Risk of Aggressive Prostate Carcinoma

doi: 10.1002/pros.21098

Figure Lengend Snippet: Risk of aggressive prostate cancer associated with the CASP8 D302H polymorphism

Article Snippet: Our interest was to determine if this variant was related to aggressive prostate cancer, in materials from two case control studies of aggressive prostate cancer at Washington University and Johns Hopkins University and in aggressive cases of this disease identified in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

Techniques: